Further trials could also vet a possible trend toward less progression in myocardial damage with eplerenone, suggested by 12‐month change in LGE, noting that follow‐up CMR data were missing in 6 of 52 subjects.
← all excerpts
Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial.
1
—
—